Patients with primary aldosteronism induced hypertension are more likely to experience cardiovascular events compared to patients with essential hypertension.
indicate that patients with PA are more likely to experience cardiovascular events and renal complications compared to patients with essential hypertension (EH). [2] [3] [4] These findings suggest that primary aldosteronism might have distinct adverse effects on cardiovascular structure and function, independent of hypertension.
Aldosterone overproduction leads to changes in vascular morphology, such as smooth muscle hypertrophy and collagen deposition within the extracellular matrix. 5, 6 As a result, patients with PA have more pronounced fibrosis in the small resistance arteries. 7 Intima-media thickness (IMT), which can be assessed through ultrasound of the common carotid artery, is used as a marker of atherosclerosis. 8 Early studies reported that common carotid intima-media thickness (CC-IMT) is higher in patients with PA compared to patients with EH patients. 9, 10 However, these studies were performed more than a decade ago. A more recent study reported no significant differences in baseline CC-IMT between subtypes of PA and EH patients. 11 Therefore, it remains debatable whether the subtypes of PA (ie, APA and IAH) exhibit different effects on cardiovascular structure.
Besides vascular structure, aldosterone also has profound effects on endothelial function. Aldosterone reduces endotheliumdependent vasodilation, either directly or through angiotensin II.
In experimental studies, it has been demonstrated that aldosterone prevents inducible nitric oxide (NO) synthase. 12 Flow-mediated dilation (FMD), which can be assessed with ultrasound of the brachial artery pre-and post-occlusion, is a widely used tool to directly and non-invasively evaluate endothelium-dependent vascular function. 13 Numerous studies have demonstrated that FMD is associated with the development of cardiovascular disease. 14, 15 Although some studies reported that hypertensive patients with PA have lower FMD compared to patients with EH, 16, 17 endothelial function paradoxically improves after 2 weeks of aldosterone excess. 18 Recently, it has been suggested that the detrimental effects of aldosterone overproduction are much less prominent in IAH than in APA, causing patients with PA due to IAH to have similar endothelial function as patients with EH.
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Given the high prevalence (20%) of PA among patients with resistant hypertension, it is crucial to further elucidate the pro-atherogenic role of PA. 20 Therefore, the aim of the present study was to investigate the influence of PA and its subtypes on vascular structure and function, as assessed by CC-IMT and FMD. 
| MATERIAL S AND ME THODS

| Diagnosis of primary aldosteronism
Screening and diagnosis of PA were conducted according to the guidelines of the Endocrine Society. 22 As a first step, screening for PA was performed by sampling plasma aldosterone concentration (PAC) and plasma renin activity (PRA). Patients with PAC > 15 ng/ dL and plasma aldosterone/renin ratio (ARR) >20 were subjected to a saline infusion test or captopril challenge test to confirm the diagnosis of PA.
Saline infusion tests were regarded as positive if PAC was still >10 ng/dL following a 4-hours, 2L intravenous infusion of saline. In 5 patients with ARR > 20 and severe systolic hypertension, saline infusion was replaced by a captopril challenge test. Captopril challenge tests were regarded positive if PAC remained elevated and PRA remained suppressed 1 hour after receiving 25-50 mg of captopril orally. 22 In patients with confirmed PA, subtype classification was performed using computed tomography (CT) and/or magnetic resonance (MR) imaging of the adrenal glands.
| Echocardiography
All patients underwent standard echocardiography using two-di- 
| Assessment of intima-media thickness
Ultrasound of the carotid artery was performed using a multifre- 
| Assessment of flow-mediated dilation
Endothelium-dependent FMD was evaluated as described previously, using a multifrequency (12 MHz) linear array transducer. 25, 26 Patients were placed in supine position, in a quiet, air-conditioned Brachial artery diameter was assessed by measuring the distance between the two lumen-intima interfaces at end-diastole. Three measurements were performed at baseline and post-occlusion.
Baseline and post-occlusive measurements were subsequently averaged. FMD was defined as the relative increase in brachial artery diameter ((diameter post-occlusion − basal diameter)/basal diameter) × 100)).
Echocardiography, assessment of intima-media thickness, and assessment of flow-mediated dilation were performed by consensus of two experienced cardiac ultrasonographers (AD and AE), who were blinded to clinical data (eg, cause of hypertension).
| Statistical analysis
Continuous variables are presented as mean ± standard deviation or median with interquartile range and were compared between two groups using the student t test for normally distributed data and Mann-Whitney test for non-parametric data. Categorical variables are expressed as frequency (percentage) and were compared between two groups using a chi-square test. Multiple group comparisons were performed by one-way analysis of variance (ANOVA), Kruskal-Wallis, or chi-square test according to variable type and distribution. Linear regression analysis was used to assess whether differences in FMD and CC-IMT remained significant after correcting for age, sex, diabetes mellitus, 24-hours systolic and diastolic blood pressure, and smoking. Association between continuous variables was quantified by Spearman's correlation.
Log transformation was applied to hormone levels in order to achieve parametric distribution. 
| RE SULTS
Clinical characteristics of the study cohort are listed in Table 1 .
Patients with PA matched well with EH patients for age, gender, body mass index, and other cardiovascular risk factors. In addition, no differences in 24-hours average systolic and diastolic blood pressures were present, nor did the duration of hypertension differ be- As expected, hypokalemia was more frequently present in patients with PA compared to patients with EH (48% vs 2.4%, P < 0.01).
Within the group of PA, hypokalemia was more frequently observed in patients with APA than patients with IAH (80% vs 31%, P = 0.01). 
| Intima-media thickness
| Flow-mediated dilation
| Hormonal levels
As expected, patients with PA demonstrated higher PAC and ARR values and lower PRA values compared to patients with EH (P < 0.01). In addition, no significant difference was observed for PAC, ARR, and PRA between subtypes of PA (P > 0.05). Table 2 ARR (r = −0.38, P < 0.01) and PRA (r = 0.36, P < 0.01), but not with PAC (r = −0.22, P = 0.08). After correcting for systolic blood pressure, both PRA and ARR were still significantly associated with FMD (both P < 0.05).
| D ISCUSS I ON
The present study is the first to perform combined assessment of vascular structure and function in patients with primary aldosteronism F I G U R E 3 Relationship between FMD, CC-IMT and hormone levels. Relationship between common carotid intima-media thickness (CC-IMT) (left), flow-mediated dilation (FMD) (right), and levels of hormones pertaining to the renin-angiotensin-aldosterone system. Both patients with PA and EH are included (n = 70). EH and subgroups of PA are also represented with different symbols. ARR, aldosterone/renin ratio; EH, essential hypertension; PA, primary aldosteronism; PAC, plasma aldosterone concentration; PRA, plasma renin activity using flow-mediated dilation and common carotid intima-media were treated with more aggressive doses of MRA achieving a remarkable rise of renin was comparable with EH patients, whereas the excessed risk remained limited to the patients with PA whose renin activity remained suppressed suggesting tailored MR antagonist therapy may be a more effective approach to reduce the increased cardiovascular risk for patients with PA treated medically.
| Primary aldosteronism as an independent risk
As a particular advantage of our study, we found no significant difference between patients with PA and EH for IVST, PWT, and diastolic dysfunction which supports a comparable blood pressure load. Consequently, our study suggests that PA affects both cardiovascular structure and function and does so independent of blood pressure. However, when evaluating parameters reflecting organ damage, only the percentage of proteinuria and levels of creatinine were higher in patients with PA compared to control. We hypothesize that differences in clinical and biochemical parameters are less prominent in our study due to relatively small number of the patients. Nevertheless, this study underlines the detrimental effect of hyperaldosteronism on vascular function and structure.
| Subtype classification of primary aldosteronism
Therapeutic approaches in PA significantly and distinctly differ depending on the lateralization finding; thus, application of an accurate technique for subtype classification is great of importance.
The recent guidelines of the Endocrine Society advocated AVS as the gold standard to distinguish between subtypes of PA suggesting use of CT as a stand-alone technique only for young patients (<35 years) with spontaneous hypokalemia and marked aldosterone excess. 22 However, CT may underdiagnose adenomas below 10 mm in diameter due to insufficient spatial resolution, whereas successive AVS demonstrates high sensitivity and specificity (95% and 100%, respectively) to distinct lateralization. 
| Vascular structure
Experimental studies have shown that excess of aldosterone stimulates vascular smooth cell hypertrophy, adventitial cell migration, and collagen accumulation in the extracellular matrix. [5] [6] [7] These structural changes ultimately result in vascular remodeling which might explain the increased cardiovascular events in patients with PA. IMT is a valid and useful tool to investigate vascular structural changes.
In several studies, a remarkable relationship was demonstrated between IMT and cardiovascular risk factors. 37, 38 IMT is therefore accepted as a solid marker of the intermediate phase of atherosclerosis.
In the present study, we found that patients with PA had significantly higher CC-IMT compared to patients with EH. These findings are in line with previous studies. Two studies found that patients with PA have greater IMT compared to patients with EH. 9, 10 Recent studies even demonstrated that IMT regressed in patients with PA who received specific medical and/or surgical treatment, suggesting that cardiovascular damage resulting from aldosterone overproduction is reversible. 11, 39, 40 Although the relationship with PA and increased CC-IMT is well established, data on the differences between subtypes are conflicting. While Matsuda et al reported that patients with IAH have higher CC-IMT compared to patients with APA, Holaj et al observed no differences in CC-IMT between subtypes. 11, 39 However, in the study performed by Matsuda et al, patients with IAH were older and had higher blood pressure, which could explain the results. In the present study, we found no significant differences in CC-IMT between subtypes of PA, which implies that influences of PA on cardiovascular structure in APA and IAH may not differ. However, differences in CC-IMT may have been obscured due to the relatively small sample size. Therefore, larger studies comparing the effects of APA and IAH on cardiovascular structure are warranted.
| Endothelial function
Aldosterone also exhibits adverse effects on endothelial function.
Aldosterone was reported to directly limit NO production by decreasing NO synthase activity and increasing superoxide anion generation in endothelial cells. 41 However, aldosterone levels were also found to be higher in patients with APA compared to patients with IAH. The attenuated post-occlusive response can therefore not solely be attributed to subtype.
In the present study, aldosterone levels were similar between patients with mass and hyperplasia and no differences in FMD were observed between the subtypes.
| Hormonal data
In the present study, no correlation was found between IMT and hormone levels (PAC, PRA, ARR). These results are in accordance with literature. 9, 10 Furthermore, a previous study found no correlation between PAC and regression of IMT after treatment of PA.
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These apparently inconsistent findings can be explained by several reasons. Firstly, blood samples were collected 2 weeks after discontinuation of medical therapy, and therefore, the hormonal levels during the chronic phase might differ. Secondly, additional factors such as density of aldosterone receptors may vary depending on the region and can be determinative in the occurrence and severity of the vascular damage, as well.
In the present study, FMD correlated significantly with ARR and also PRA, whereas no correlation was detected between FMD and PAC. The association of FMD with both ARR and PRA remained sig- 
| Implications and future perspectives
These data clearly confirm that exposure to inappropriate aldosterone overproduction for sodium levels is associated with increased cardiovascular risk by altering both cardiovascular structure and function. As a consequence, the pro-atherogenic effects of PA need to be strictly monitored during daily clinical practice in patients with PA, even if blood pressure has normalized. Recently, the German Conn's Registry showed that cardiovascular mortality is higher in patients with PA compared to patients with EH (50% vs 34%). 
| S TUDY LIMITATI ON S
This study has some important limitations. First, as previously mentioned, the number of patients with PA is relatively small, particularly for APA (10) , which may have precluded the comparison between PA subtypes, as well as differences in clinical and biochemical parameters. Second, adrenal vein sampling (AVS), which is the preferred method for subtype classification of PA as recommended by the latest guideline of the Endocrine Society, was attempted in only four patients. 22 Because of the low success rate of the procedure, the procedure was not performed in the remainder of patients. However, subtyping was performed using CT and/or MR imaging for all the patients with confirmed PA. Nevertheless, the results regarding comparison between subtypes of PA should be interpreted cautiously, since the distinction of subgroups is not definitive. Finally, a true control group is missing. However, the rationale of the study was able to assess the severity of atherosclerotic features in the patients with PA in comparison to patients with EH.
| CON CLUS IONS
Primary aldosteronism appears to exhibit deteriorative effects on both vascular structure and function, as determined with carotid intima-media thickness and flow-mediated dilation, independent of hypertension.
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